Whalegun
Lobbying

Definium Therapeutics Inc.)'s latest lobbying report covers Q2 2026, at $170K. The four quarters Q4 2025–Q3 2026 total $500K. Its first report covers Q4 2024; the issues it reports most are Health Issues.

Definium Therapeutics Inc.)

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$500K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2024
The first quarter a report named it

Lobbying by quarter

Definium Therapeutics Inc.) lobbying by quarter
Definium Therapeutics Inc.) lobbying by quarter
QuarterAmountReports
Q4 2024$60K1
Q1 2025$160K2
Q2 2025$150K2
Q3 2025$150K2
Q4 2025$150K2
Q1 2026$180K2
Q2 2026$170K2
Q3 2026$00

By issue

  • Health issues$1M · 13 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES13 reports
  • SENATE13 reports
  • Health & Human Services, Dept of (HHS)1 reports
  • Veterans Affairs, Dept of (VA)1 reports

Firms it paid

Firm
In-houseDefinium Therapeutics Inc.)$560K6 quarters
The Conafay Group$460K7 quarters

Former officials lobbying for it

Former position
DARIN L GARDNERLegislative Correspondent Senator Tim Hutchinson;ResearchAssistant Senate HELP Committee; Chief ofStaffCongresswoman Kay GrangerQ2 2026
JOSH NARROWIntern to Sen. CaseyQ2 2026

Lobbying reports

Filed by
07/20for Q2In-house$90K
07/20for Q2The Conafay Group$80K
04/20for Q1The Conafay Group$80K
04/15for Q1In-house$100K
01/20for Q4 2025The Conafay Group$60K
01/20for Q4 2025In-house$90K
25/10/20for Q3 2025In-house$90K
25/10/20for Q3 2025The Conafay Group$60K
25/07/18for Q2 2025The Conafay Group$60K
25/07/18for Q2 2025In-house$90K
25/04/21for Q1 2025In-house$100K
25/04/18for Q1 2025The Conafay Group$60K
25/04/16for Q1 2025In-houseUnder $5,000
25/01/17for Q4 2024The Conafay Group$60K
24/11/07for Q4 2024The Conafay GroupUnder $5,000